Trombose de veia porta não associada à cirrose – desafio terapêutico
Non-cirrhotic portal vein thrombosis – therapeutic challenge
Lucas Mansano Sarquis; Paula de Oliveira Trintinalha; Wilson Michaelis; Antonio Lacerda Santos Filho; Rogerio Akira Yokoyama; Thiago Michaelis; Adriana Pires Smaniotto; Mariana Santos Oliveira
Resumo
Palavras-chave
Abstract
Portal vein thrombosis (PVT) is a disease in which thrombosis occurs from the intrahepatic branches of the portal vein, and may extend to the splenic vein and/or superior mesenteric vein. It is most often associated with liver cirrhosis. PVT not associated with cirrhosis is rare. The aim of this article is to report two cases of PVT in which it was not associated with cirrhosis. Both were treated with anticoagulation and clinical progress afterwards was good.
Keywords
References
1 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5(1):22-40.
2 Qi X. Portal vein thrombosis: recent advance. Adv Exp Med Biol. 2017;906:229-39.
3 Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019;113:86-91.
4 Salembier A, Verhamme M, Verhamme P, Van Moerkercke W. Acute non-cirrhotic portal vein thrombosis: review. Acta Gastroenterol Belg. 2018;81(2):318-22. PMid:30024704.
5 Sabol TP, Molina M, Wu GY. Thrombotic venous diseases of the liver. J Clin Transl Hepatol. 2015;3(3):189-94.
6 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: when to treat and how? Vasc Med. 2016;21(1):61-9.
7 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 2019;156(6):1582-99.e1.
8 Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant. 2018;23(2):250-6.
9 Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis. Int J Hepatol. 2018;2018:8432781.
10 Ghazaleh S, Beran A, Aburayyan K, et al. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis. Ann Gastroenterol. 2021;34(1):104-10. PMid:33414629.
11 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;153(2):480-487.e1.
12 Mohan BP, Aravamudan VM, Khan SR, Ponnada S, Asokkumar R, Adler DG. Treatment response and bleeding events associated with anticoagulant therapy of portal vein thrombosis in cirrhotic patients: systematic review and meta-analysis. Ann Gastroenterol. 2020;33(5):521-7.
13 Shatzel JJ, O’Donnell M, Olson SR, et al. Venous thrombosis in unusual sites: a practical review for the hematologist. Eur J Haematol. 2019;102(1):53-62.
14 Vianna R, Beduschi T. Multivisceral transplantation for diffuse splanchnic venous thrombosis. Curr Opin Organ Transplant. 2016;21(2):201-8.
Submitted date:
01/16/2021
Accepted date:
12/01/2021
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email